127 related articles for article (PubMed ID: 36824585)
1. Paediatric Society and Hyperinsulinism Charity National Surveys on CGM Access for Patients With Recurrent Hypoglycaemia.
Ng SM; Dearman S; Fisher M; Mushtaq T; Randell T
J Endocr Soc; 2023 Feb; 7(4):bvad021. PubMed ID: 36824585
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
3. Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis.
Worth C; Harper S; Salomon-Estebanez M; O'Shea E; Nutter PW; Dunne MJ; Banerjee I
J Med Internet Res; 2021 Oct; 23(10):e26957. PubMed ID: 34435596
[TBL] [Abstract][Full Text] [Related]
4. Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset.
Worth C; Tropeano Y; Gokul PR; Cosgrove KE; Salomon-Estebanez M; Senniappan S; Dastamani A; Banerjee I
BMJ Open Diabetes Res Care; 2022 Jun; 10(3):. PubMed ID: 35675953
[TBL] [Abstract][Full Text] [Related]
5. The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia.
Vijayanand S; Stevenson PG; Grant M; Choong CS; Davis EA; Abraham MB
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1567-1572. PubMed ID: 34520640
[TBL] [Abstract][Full Text] [Related]
6. The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism.
Worth C; Dunne MJ; Salomon-Estebanez M; Harper S; Nutter PW; Dastamani A; Senniappan S; Banerjee I
Front Endocrinol (Lausanne); 2022; 13():1016072. PubMed ID: 36407313
[TBL] [Abstract][Full Text] [Related]
7. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring in Children with Type 1 Diabetes Improves Well-Being, Alleviates Worry and Fear of Hypoglycemia.
Ng SM; Moore HS; Clemente MF; Pintus D; Soni A
Diabetes Technol Ther; 2019 Mar; 21(3):133-137. PubMed ID: 30785768
[TBL] [Abstract][Full Text] [Related]
9. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
10. Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study.
Litchman ML; Allen NA
J Diabetes Sci Technol; 2017 Sep; 11(5):988-995. PubMed ID: 28376647
[TBL] [Abstract][Full Text] [Related]
11. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
[TBL] [Abstract][Full Text] [Related]
12. Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year.
Chamberlain JJ; Dopita D; Gilgen E; Neuman A
J Diabetes Sci Technol; 2015 Sep; 10(2):383-8. PubMed ID: 26353781
[TBL] [Abstract][Full Text] [Related]
13. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
[No Abstract] [Full Text] [Related]
14. Is Continuous Glucose Monitoring Underappreciated in the UK?
Parkin CG; Holloway M; Truesdell J; C Walker T
Eur Endocrinol; 2017 Aug; 13(2):76-80. PubMed ID: 29632612
[TBL] [Abstract][Full Text] [Related]
15. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
16. Families' Experiences of Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A Thematic Analysis.
Auckburally SH; Worth C; Salomon-Estebanez M; Nicholson J; Harper S; Nutter PW; Banerjee I
Front Endocrinol (Lausanne); 2022; 13():894559. PubMed ID: 35928891
[TBL] [Abstract][Full Text] [Related]
17. Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus.
Sandy JL; Nyunt O; Woodhead HJ; Youde LS; Ramjan KA; Jack MM; Lim L; Shepherd M; Marshall A; Townsend N; Wilson S; Duke SA; Slavich E; Hameed S
J Paediatr Child Health; 2019 Sep; 55(9):1056-1062. PubMed ID: 30565355
[TBL] [Abstract][Full Text] [Related]
18. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
[TBL] [Abstract][Full Text] [Related]
19. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives.
Pickup JC; Ford Holloway M; Samsi K
Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422
[TBL] [Abstract][Full Text] [Related]
20. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
